Botox 200 unit vials
Ended Awarded Last action
- Contract number
- SPE2DR26FHNR0
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,805
Award facts
- Contract value 100% obligated
- $19,804.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $19.8K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for BOTOX 200 Unit Vials. This delivery order, awarded on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award falls under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) established through the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion federal acquisition strategy designed to provide comprehensive pharmaceutical supply support to military healthcare facilities worldwide.
DMS Pharmaceutical Group holds a single-award IDC designated as contract SPE2DR, valued at $499.99 billion with a completion date of December 31, 2036, featuring a 30-month base period and three 30-month option periods. The company's established performance across numerous delivery orders demonstrates its capability as a critical pharmaceutical supplier for Department of Defense healthcare operations globally, with a product portfolio encompassing branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. As a registered federal contractor since 2001 with substantial contracting activity through the Defense Logistics Agency's Medical Supply Chain division, DMS Pharmaceutical Group leverages its small business status to serve as one of multiple regional prime vendor contractors supporting the military medical system's diverse and specialized pharmaceutical requirements.
Quick answers
Who was awarded contract SPE2DR26FHNR0?
SPE2DR26FHNR0 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DR26FHNR0 worth?
The government has obligated $19,805 on SPE2DR26FHNR0.
Is contract SPE2DR26FHNR0 an order under another contract?
Yes. SPE2DR26FHNR0 is a delivery order under SPE2DR25D9231, an indefinite delivery contract.
Was contract SPE2DR26FHNR0 competed?
The extent of competition for SPE2DR26FHNR0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award